Popular Articles

FDA Advisory Panel Recommends Approval Of The SEDASYS(R) System
Ethicon Endo-Surgery today announced that the Anesthesiology and Respiratory Therapy Devices Advisory Committee of the U.S. Food and Drug Administration (FDA) voted in favor of approval of the SEDASYS(R) System for use by physician/nurse teams to administer minimal-to-moderate propofol sedation during screening and diagnostic procedures for colorectal cancer (colonoscopy) and the upper gastrointestinal tract (EGD). The SEDASYS(R) System, the first computer-assisted personalized sedation (CAPS) system, integrates drug delivery and patient monitoring to enable propofol sedation personalized to each patient"s needs.

Swine Flu Media Bulletin Issued At: 11am Thursday 21 May 2009, Wales
- 0 confirmed cases in Wales.
News of the day
Improvements In Prevention And Cardiac Care Mean Fewer Heart Attacks And Fewer Deaths
A new report tracking selected indicators of health system performance over 10 years in Canada shows significant improvements in the prevention and management of heart disease, with fewer Canadians having a heart attack, one of the leading causes of death in this country. Data from the Canadian Institute for Health Information (CIHI) shows the rate of patients admitted to hospital for heart attack in Canada (outside Quebec) dropped 13% between 2003-2004 and 2007-2008, after population growth and aging were taken into account. Over the same time period, deaths in hospital within 30 days of admission for acute myocardial infarction (AMI), or heart attack, were down 11%, and unplanned readmissions to hospital after a heart attack declined by 31%. Health Indicators 2009 marks the 10th anniversary of CIHI"s annual report. Produced with Statistics Canada, the report provides more than 40 comparable measures of health and the health system by health region, province and territory.
Medical Devices

Vetericyn Inc. Launches Equine Wound & Infection Product Utilizing FDA-Cleared Technology

Vetericyn Inc., a California-based animal healthcare company, has announced the launch of its new Vetericyn™ equine product, available in a 16-ounce trigger spray for horses. Vetericyn™ utilizes an FDA-cleared technology that has been used to successfully treat over one million human patients without a single serious adverse effect. Now, the innovative topical wound-care product is available to the animal healthcare market. Vetericyn™ is the first non-toxic broad-spectrum antimicrobial on the market. The landscape-altering wound and infection control technology works naturally with the animal"s immune system to kill bacteria (including staph and drug-resistant MRSA), viruses, fungi and spores without harming healthy tissue. Vetericyn™ utilizes a proprietary and non-cytotoxic formulation of an oxychlorine compound, similar to that produced by the animal"s own immune system, which can be applied locally to an infection site to facilitate healing. Key benefits of Vetericyn™ include: - Broad spectrum infection treatment - Vetericyn™ is scientifically designed to treat a wide variety of wounds, skin ulcers and abrasions. It can be used to treat hot spots, ring worm, pigeon fever, rain and cinch rot, eye and ear infections, fungal infections, skin rashes, cuts and burns, post-surgical incisions and topical infections. - Accelerated healing time - Wounds treated with Vetericyn™ have demonstrated a reduction in healing time of up to 60 percent. In vitro results show that Vetericyn™ can safely kill 99.9999 percent of most single-cell pathogens within 30 seconds. Treatment with Vetericyn™ more than doubles the oxygen supply at the wound site within 30 seconds and maintains that level for up to 36 hours. This increased oxygen and the eradication of infection are responsible for the accelerated healing time. - Reduces inflammation and eliminates odor - Vetericyn™ inhibits the release of histamines which causes chronic wound inflammation. Wound odor is also eliminated by killing bacteria, helping to keep flies and other pests away from outdoor animals during treatment. - Safe as water - Vetericyn™ is pH neutral and can be used safely in the eyes, mouth and nose without stinging, irritation or shock. It will not cause injury if ingested by animals. Because Vetericyn™ works in the same way as an animal"s immune system, the body recognizes it as a friendly infection-treating ally. - Convenient for anyone to use anywhere - As a one-step cleanser and dressing, Vetericyn™ eliminates the need for multiple products and treatment steps, allowing for the healing to begin immediately. Vetericyn™ is ready for immediate use with no mixing or dilution required. Unlike betadine or iodine, gloves and other safety equipment are not required to apply Vetericyn™ and there is no staining or mess. Vetericyn™ is a "no-rinse" formula, leaving no film or residue that needs to be cleaned off the animal. - Extended shelf life, remains sterile - Unlike saline, a container of Vetericyn™ will remain sterile after opening. Users simply recap tightly and store at room temperature out of direct sun. Electrolyzed water has been in use for decades, but past formulations have limited shelf life. Vetericyn has a shelf life of 18 months. - Environmentally friendly - Vetericyn™ is as safe on the environment as it is on the patient. The non-toxic, pH neutral formula does not require any special handling or disposal precautions. Vetericyn solution is 100 percent biodegradable. - Safe for Competition - Vetericyn™ is steroid- and antibiotic-free. Because it contains no banned substances, it "tests free" on competitive horses. The 16-ounce trigger spray formula is ideal for large animals. It should be sprayed directly on animals to treat wounds. Vetericyn can also be used as a preventative measure by spraying on tack and blankets that are moved from animal to animal. The product fits conveniently in a saddlebag, and riders are encouraged to take Vetericyn™ along on rides in order to treat any injuries as soon as they occur. Vetericyn Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):